Printer Friendly
The Free Library
14,800,529 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Browse Biotechnology industry topic

Investigations subtopic

 

Articles

1-37 out of 37 article(s)
Title Author Type Date Words
Stull, Stull & Brody Announces Investigation on Behalf of Shareholders of Trimeris, Inc. Nov 6, 2009 298
Law Offices of Howard G. Smith Announces Investigation On Behalf of Shareholders of Trimeris, Inc. Oct 19, 2009 222
Levi & Korsinsky, LLP Investigates Possible Breach of Fiduciary Duty by the Board of Trimeris, Inc. - TRMS. Oct 16, 2009 233
Law Office of Brodsky & Smith, LLC Announces Investigation on Behalf of Shareholders of Trimeris, Inc. Oct 16, 2009 213
Sequenom fires execs over mishandled research data. Chambers, Heather Brief article Oct 5, 2009 161
Wolf Haldenstein Investigates Facet Biotech Offer Rejection. Sep 4, 2009 203
Facing ITC Investigation? Aug 17, 2009 1465
Hagens Berman Investigating Potential Securities Violations at Genzyme Corporation (GENZ) on Behalf of Investors. Aug 3, 2009 297
Genzyme Corporation (GENZ) Target of Investigation for Potential Securities Law Violations, Hagens Berman Announces. Jul 31, 2009 353
SEC launches Sequenom probe. Chambers, Heather Brief article Jul 6, 2009 124
Law Offices of Howard G. Smith Announces Investigation on Behalf of Shareholders of Cougar Biotechnology, Inc. May 27, 2009 193
CellCyte agrees to settle SEC investigation. May 19, 2009 357
Law Offices of Howard G. Smith Announces Investigation On Behalf of Investors of Sequenom, Inc. Apr 30, 2009 220
CellCyte runs out of cash, closes; Fails to pay rent; From soaring profits to shareholder lawsuits to SEC probe for biotech. Dec 24, 2008 351
Integrated DNA Technologies, Inc., First Licensee under Applied Biosystems' Real-Time PCR Probe Licensing Program. Oct 16, 2008 441
Feds probe biotech sites for pointers. York, Tom Sep 29, 2008 520
Global Bio-Chem Technology Group Company Limited, Foley Hoag LLP, and Adduci, Mastriani & Schaumberg LLP Prevail in International Trade Commission Patent Infringement Investigation. Jul 31, 2008 532
Research and Markets: Cytokinetics is the First Company to Systematically Investigate the Cytoskeleton and Molecular Motors as Possible Drug Targets for Cancer and Cardiovascular Diseases. Company overview May 28, 2008 398
SEC upgrades CellCyte probe; Increased scrutiny; Bothell company ''to fully cooperate'' with investigation of material in filings. May 16, 2008 330
CombiMatrix Molecular Diagnostics to Utilize Autism Probe Content from a Partnership with The Centre for Applied Genomics. Mar 7, 2007 861
Cell Therapeutics agrees to settle; To pay $10.5 million; Allegations of improper marketing of cancer drug spurred U.S. investigation. Jan 24, 2007 487
GeneDetect Announces Intention to Divest Popular Branded GeneDetect(R) and GreenStar Hyperlabeled Gene Probe Product Ranges. Aug 1, 2006 376
Life Sciences Companies Face Special Disclosure Challenges. Garcia, Sergio Mar 15, 2006 2857
FDA orders Biomedical Tissue Services to cease practicing; lawmakers, lawyers also taking action. Warren, Jim Feb 13, 2006 1029
Late COA for reference standard noted in EIR for CRO. Feb 1, 2006 432
Cloned baby "Eve" reported to be in Israel; success remains in doubt. Jan 31, 2003 210
Tissue contamination prevention measures give Regeneration good audit. (Blood/Biologics). Witkowski, Wallace Aug 1, 2002 537
Foot & Mouth Outbreak GM Vaccine and Biowarfare. (Biodevastation). Ho, Mae-Wan Jan 1, 2002 1284
Eight Pretty Bad Corporations. Brief Article May 1, 2001 248
FDA wants approved kits used in stem cell draws. Feb 1, 2000 3348
Design validation faulted at Witt Biomedical cardiac site. Brief Article Aug 1, 1999 143
Software, process validation key focuses of Baxter catheter audit. Brief Article Apr 1, 1999 212
Predecessor's ways don't please FDA, Zymed finds. Mar 1, 1999 1277
Biopharm Requests FDA Hearing in Regard to New Drug Applications. Aug 31, 1998 265
Respironics Inc. announces receipt of warning letter from United States Food and Drug Administration. Dec 30, 1994 350
FDA investigation deemed not material to Genentech; FDA scrutiny of promotional practices reported in media since August. Nov 10, 1994 396
Government probes gene-splice test. Miller, Julie Ann Mar 8, 1986 591

Terms of use | Copyright © 2010 Farlex, Inc. | Feedback | For webmasters | Submit articles